Sano y salvo on X: "Declaración conjunta de la @EMA_News y el @ECDC_EU sobre la posibilidad de usar dos vacunas #COVID19 diferentes, tanto para las dos primeras dosis como para la tercera
Covid-19 vaccine mixing: could heterologous boosters improve immunity?
Study finds heterologous vaccine booster evokes robust immunity to SARS-CoV-2 Omicron variant
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination | NEJM
A different take on swine influenza vaccination - Articles - pig333, pig to pork community
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study - The Lancet Global Health
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant | Signal Transduction and Targeted Therapy
COVID-19: safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine (Sputnik V)
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines: Expert Review of Vaccines: Vol 22, No 1
Study shows enhanced immunogenicity of heterologous boosting strategy in individuals primed with J&J vaccine
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine
Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine - ScienceDirect
Heterologous booster schedules are associated with increased protection against severe, omicron related COVID-19 outcomes
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses | The BMJ
Strategies and safety considerations of booster vaccination in COVID-19 | Biomolecules and Biomedicine
Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans | NEJM
Heterologous Covid-19 Booster Vaccinations | NEJM
Explained | What is a heterologous booster vaccine, and what are its advantages? - The Hindu
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
What is a heterologous booster vaccine? | The Hindu - YouTube
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination | Nature Medicine
